NPI: 1467414565 · LAS VEGAS, NV 89148 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,381 | $193K |
| 2019 | 25,154 | $228K |
| 2020 | 16,818 | $225K |
| 2021 | 21,252 | $268K |
| 2022 | 22,141 | $201K |
| 2023 | 1,780 | $50K |
| 2024 | 1,705 | $77K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 34,919 | 1,595 | $1.24M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,561 | 968 | $1K |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,140 | 576 | $16.11 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 119 | 45 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 30 | 13 | $0.00 |
| 83550 | 1,527 | 721 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 2,559 | 1,044 | $0.00 |
| 82728 | 1,757 | 784 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 275 | 96 | $0.00 |
| 85041 | 2,115 | 836 | $0.00 | |
| 83970 | 1,626 | 624 | $0.00 | |
| 85048 | 2,086 | 827 | $0.00 | |
| 83540 | 1,774 | 761 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 4,594 | 623 | $0.00 |
| 82108 | 91 | 51 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 58 | 14 | $0.00 |